The Malaysian Medical Association (MMA) has issued a stark warning against the illicit trade of diabetes medications for weight loss, emphasizing the potential dangers and ethical concerns surrounding this practice. The association is taking a strong stance against doctors leasing their credentials to beauty clinics that supply prescription diabetes drugs without proper medical oversight.
'A Letter of Credentialing and Privileging (LCP) is not a tradable document,' emphasized Dr. Thirunavukarasu Rajoo, the MMA president. 'It is a professional document tied to an individual doctor’s competence, clinical judgment, and accountability.' This statement underscores the critical responsibility doctors bear for patient care, even when they are not physically present at the clinics.
The issue came to light after reports emerged that people were purchasing prescription drugs like semaglutide and tirzepatide (commonly known as Ozempic and Mounjaro) from beauty clinics without undergoing the necessary health checks and screening procedures. Social media users were openly admitting to bypassing prescriptions and sharing contact details of clinics willing to sell the drugs for between RM700 and RM2,000.
Dr. Thirunavukarasu criticized the sale of these 'potent metabolic medications' as quick cosmetic solutions, emphasizing that they are not 'lifestyle shortcuts'. 'Semaglutide and tirzepatide were developed for specific clinical indications, including diabetes and obesity management under structured medical supervision,' he noted. 'Prescribing these medicines without proper history-taking, risk assessment, baseline investigations, counseling, and follow-up exposes patients to preventable harm.'
The side effects of these medications can range from severe gastrointestinal symptoms and dehydration to more serious complications. Dr. Thirunavukarasu assured that the MMA would support investigation and enforcement actions by the authorities and urged the public to exercise caution. 'Patients should verify that their doctor is properly registered and that consultations include appropriate assessment and counseling. No injection or procedure is risk-free, and informed consent requires full disclosure of benefits, risks, and alternatives,' he advised.
This controversy raises important questions about the ethical boundaries of medical practice and the responsibility of doctors in the face of emerging trends in healthcare. What are your thoughts on this issue? Do you agree with the MMA's stance, or do you think there are other perspectives to consider? Share your thoughts in the comments below.
